Skip to search formSkip to main contentSkip to account menu

mepolizumab 100 MG Injection [Nucala]

Known as: MEPOLIZUMAB 100 mg in 1 mL SUBCUTANEOUS INJECTION, POWDER, FOR SOLUTION [Nucala], Nucala 100 MG Injection 
National Institutes of Health

Related topics

Related topics

6 relations
InjectionNucalaPolysorbate 80Sucrose

Broader (1)

mepolizumab Injection [Nucala]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Monoclonal antibody therapy for the treatment of asthma and chronic obstructive pulmonary disease with eosinophilic inflammation
2017
2017
Near-fatal asthma responsive to mepolizumab after failure of omalizumab and bronchial thermoplasty
Severe asthma affects between 5% and 10% of patients with asthma worldwide and requires best standard therapies at maximal doses… 
2017
2017
Mepolizumab (Nucala°) in asthma.
  • Prescrire international
  • 2017
  • Corpus ID: 73426961
Review
2016
Review
2016
Mepolizumab: A Review in Eosinophilic Asthma
Mepolizumab (Nucala®) is a humanized monoclonal antibody against interleukin-5, a cytokine involved in the development… 
2016
2016
[Facilitated patient management with low molecular weight heparin].
2016
2016
[Oral steroids downgraded, biologics upgraded].
2016
2016
Orale Steroide zurückgestuft, Biologika aufgewertet
  • D. Einecke
  • MMW - Fortschritte der Medizin
  • 2016
  • Corpus ID: 195342839
_ Orale Steroide (OCS) sind bei schwerem Asthma unverzichtbar, verursachen aber schwere Nebenwirkungen. Eine Statistik des German… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)